Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16863840 | 0.95 | — | — | |
| SCHEMBL17675722 | 0.91 | MAPK1 (0.31) | — | |
| SCHEMBL14227660 | 0.90 | HSP90AA1 (0.34) | ADRA2BLMNAALDH1A1KMT2A | |
| SCHEMBL17675721 | 0.89 | RAB9A (0.37) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL14359958 | 0.88 | ALDH1A1 (0.38) | LMNAALDH1A1GAAMEN1KMT2A | |
| SCHEMBL14227669 | 0.88 | ALDH1A1 (0.35) | DRD3SLC6A3SLC6A2SLC6A4LMNA | |
| SCHEMBL17676152 | 0.87 | — | — | |
| SCHEMBL14359956 | 0.81 | RXRA (0.32) | — | |
| SCHEMBL18255337 | 0.79 | LMNA (0.32) | LMNAALDH1A1 | |
| SCHEMBL1887766 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9926258-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2018-03-27 | — | — | US | disclosed |
| US-20160362356-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2016-12-15 | — | — | US | disclosed |
| US-20160347704-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160347704-A1 | PHOTOLABILE PRO-FRAGRANCES | CUTA, FAAH, FAAH2 | CHRM2 2097/4885ADRA2B 3176/4885DRD3 1526/4885 |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | CHRM2 2332/4885ADRA2B 3603/4885DRD3 1823/4885 |
| US-20160362356-A1 | PHOTOLABILE PRO-FRAGRANCES | CUTA, FAAH, FAAH2 | CHRM2 2910/4885ADRA2B 3650/4885DRD3 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.